Compare IPSC & ELVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IPSC | ELVA |
|---|---|---|
| Founded | 2019 | 1996 |
| Country | United States | Canada |
| Employees | 78 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.6M | 466.7M |
| IPO Year | 2021 | 2021 |
| Metric | IPSC | ELVA |
|---|---|---|
| Price | $2.27 | $10.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | $4.25 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 644.7K | 449.6K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $109,164,000.00 | N/A |
| Revenue This Year | N/A | $34.68 |
| Revenue Next Year | N/A | $51.48 |
| P/E Ratio | ★ N/A | $78.51 |
| Revenue Growth | ★ 1556.76 | N/A |
| 52 Week Low | $0.44 | $2.98 |
| 52 Week High | $2.97 | $11.88 |
| Indicator | IPSC | ELVA |
|---|---|---|
| Relative Strength Index (RSI) | 49.15 | 57.76 |
| Support Level | $2.15 | $7.10 |
| Resistance Level | $2.41 | $11.41 |
| Average True Range (ATR) | 0.13 | 0.89 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 56.67 | 70.34 |
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.
Electrovaya Inc is a technology-focused lithium-ion battery company engaged in designing, developing and manufacturing battery cells, modules and systems based on its proprietary Infinity Battery Technology, which provides high safety performance, long cycle life and durability. The Company supplies low-voltage and high-voltage battery systems for industrial and transportation markets, including material-handling equipment, robotic vehicles, electric buses and trucks, and energy-storage installations, and its products are suitable for mission-critical applications. it maintains an expanding intellectual-property portfolio, develops next-generation solid-state and hybrid solid-state battery technologies, and sells its products through OEM relationships, dealer networks and direct sales.